Children
Sign in to add trainee| Djahida Bouskra | grad student | 2009 | University Paris 7 |
| Igor Stzepourginski | grad student | 2014 | University Paris 7 |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lyu M, Suzuki H, Kang L, et al. (2022) ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut. Nature |
| Zhou W, Zhou L, Zhou J, et al. (2022) ZBTB46 defines and regulates ILC3s that protect the intestine. Nature |
| Pascal M, Kazakov A, Chevalier G, et al. (2022) The neuropeptide VIP potentiates intestinal innate type 2 and type 3 immunity in response to feeding. Mucosal Immunology |
| Corral D, Charton A, Krauss MZ, et al. (2022) ILC precursors differentiate into metabolically distinct ILC1-like cells during Mycobacterium tuberculosis infection. Cell Reports. 39: 110715 |
| Kawanabe-Matsuda H, Takeda K, Nakamura M, et al. (2022) Dietary Lactobacillus-derived exopolysaccharide enhances immune checkpoint blockade therapy. Cancer Discovery |
| Zhou L, Zhou W, Joseph AM, et al. (2022) Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation. Nature Immunology |
| Grigg JB, Shanmugavadivu A, Regen T, et al. (2021) Antigen-presenting innate lymphoid cells orchestrate neuroinflammation. Nature |
| Goc J, Lv M, Bessman NJ, et al. (2021) Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell |
| Vanderkerken M, Baptista AP, De Giovanni M, et al. (2021) ILC3s control splenic cDC homeostasis via lymphotoxin signaling. The Journal of Experimental Medicine. 218 |
| Hablot J, Ferhat M, Lavelle A, et al. (2020) Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis. Clinical and Translational Medicine. 10: e163 |